CpG site-specific alteration of hydroxymethylcytosine to methylcytosine beyond DNA replication.

[1]  G. Hon,et al.  Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome , 2012, Cell.

[2]  Xiaodong Cheng,et al.  Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation , 2012, Nucleic acids research.

[3]  H. Sasaki,et al.  Genomic imprinting and its relevance to congenital disease, infertility, molar pregnancy and induced pluripotent stem cell , 2012, Journal of Human Genetics.

[4]  K. Helin,et al.  DNA methylation: TET proteins—guardians of CpG islands? , 2012, EMBO reports.

[5]  Yi Zhang,et al.  Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. , 2011, Genes & development.

[6]  Yi Zhang,et al.  Replication-Dependent Loss of 5-Hydroxymethylcytosine in Mouse Preimplantation Embryos , 2011, Science.

[7]  Chuan He,et al.  Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.

[8]  S. Yagi,et al.  DNA methylation-dependent modulator of Gsg2/Haspin gene expression. , 2011, The Journal of reproduction and development.

[9]  A. Klungland,et al.  The presence of 5-hydroxymethylcytosine at the gene promoter and not in the gene body negatively regulates gene expression. , 2011, Biochemical and biophysical research communications.

[10]  Iris Antes,et al.  Recognition of 5-Hydroxymethylcytosine by the Uhrf1 SRA Domain , 2011, PloS one.

[11]  B. Ren,et al.  Integrating 5-Hydroxymethylcytosine into the Epigenomic Landscape of Human Embryonic Stem Cells , 2011, PLoS genetics.

[12]  Hidenori Akutsu,et al.  DNA Methylation Dynamics in Human Induced Pluripotent Stem Cells over Time , 2011, Human Cell.

[13]  G. Ming,et al.  Hydroxylation of 5-Methylcytosine by TET1 Promotes Active DNA Demethylation in the Adult Brain , 2011, Cell.

[14]  W. Reik,et al.  Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation , 2011, Nature.

[15]  P. Jin,et al.  Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine , 2011, Nature Biotechnology.

[16]  M. Biel,et al.  Tissue Distribution of 5-Hydroxymethylcytosine and Search for Active Demethylation Intermediates , 2010, PloS one.

[17]  Herbert M. Sauro,et al.  In-Fusion BioBrick assembly and re-engineering , 2010, Nucleic acids research.

[18]  Swati Kadam,et al.  Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine , 2010, Nucleic acids research.

[19]  T. Ushijima,et al.  Aberrant DNA methylation in contrast with mutations , 2010, Cancer science.

[20]  David R. Liu,et al.  The Behaviour of 5-Hydroxymethylcytosine in Bisulfite Sequencing , 2010, PloS one.

[21]  E. O. Ermakova,et al.  Intergenic, gene terminal, and intragenic CpG islands in the human genome , 2010, BMC Genomics.

[22]  Christian Schmidl,et al.  Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity. , 2009, Genome research.

[23]  N. Heintz,et al.  The Nuclear DNA Base 5-Hydroxymethylcytosine Is Present in Purkinje Neurons and the Brain , 2009, Science.

[24]  Masaaki Oda,et al.  QUMA: quantification tool for methylation analysis , 2008, Nucleic Acids Res..

[25]  Y. Miwa,et al.  Easy stable transfection of a human cancer cell line by electrogene transfer with an Epstein–Barr virus-based plasmid vector , 2007, Medical Molecular Morphology.

[26]  L. Sowers,et al.  Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. , 2007, Cancer research.

[27]  C. Hsieh,et al.  DNA Methylation Dictates Histone H3K4 Methylation , 2007, Molecular and Cellular Biology.

[28]  D. Botstein,et al.  A gene expression database for the molecular pharmacology of cancer , 2000, Nature Genetics.

[29]  David R. Liu,et al.  Conversion of 5-Methylcytosine to 5- Hydroxymethylcytosine in Mammalian DNA by the MLL Partner TET1 , 2009 .

[30]  A. Bird,et al.  Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). , 2004, Nucleic acids research.